Natco pharma - pharma company analysis
A financial fundamental analysis of the pharma company . This covers the growth analysis and piotroski analysis to identify accounting strength. More details can be found in the paid version of the report. Lots more @ goodinvestory.com
Published on: Mar 3, 2016
Transcripts - Natco pharma - pharma company analysis
BSE Code : 524816
NSE Code : NATCOPHARM
Sector : PHARMACEUTICALS
Report date : Thu Apr 24 06:50:53 EDT 2014
Market Cap is the price of
all the outstanding
common shares if we were
to buy it all at the current
The benchmark company
Sun Pharma in the
pharmaceuticals sector is
54 times the size of Natco
Mid Caps are a choice for
people who can take
medium volatility/risk with
higher chance of returns
Companies that have grown historically are more likely to exibit similar growth in the future. Read
the trends in the 4 year annualized profit growth, book value growth and sales growth shown
How good are the returns?
RoE is the speed at which the company might grow without sorting to additional fund raising.
RoCE is the growth speed, if the company used all the assets, including loans/preference shares.
The 2-year and 4-year values give a reasonable assurance about the growth sustenance.
Seperate Winners from Losers
The Piotroski scoring system is a nine point system to determine the strength of a firm's financial
position. The score was developed by an accounting professor out of Chicago named Joseph
Piotroski. If it scores an 8 or 9, then the fundamentals are great for the stock.
This report is prepared by the good.inve.story. software and is not prepared by an
actual person who has a CFA or any other certification.
good.inve.story. is still in BETA mode. So, please let us know if you find any errors.
We would love to hear from you.
This report is based on information obtained from public sources and sources
believed to be reliable, but no independent verification has been made nor is its
accuracy or completeness guaranteed.
This report is not an advisory to buy or sell. Please buy only if you think, this is the
right company at the right price and sell only if you don’t see any potential for
get more @ goodinvestory.com